Answers are grounded in this paper and cite their sources.
The author suggests that aprotinin offers safety and cost benefits in cardiac surgery and should be seriously considered.
many benefits. Safety is certainly one of them; cost may be another. It's time they were considered seriously.
No takes yet. Share an insight, caveat, or question.
Hunt et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: